<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01976442</url>
  </required_header>
  <id_info>
    <org_study_id>URMC RSRB00035034</org_study_id>
    <nct_id>NCT01976442</nct_id>
  </id_info>
  <brief_title>Use of Saline-Washed Platelet and Red Cell Transfusions in Adult Acute Leukemia</brief_title>
  <official_title>Impact of Washed Transfusions in Adult Patients With Acute Myeloid or Lymphoid Leukemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Rochester</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a novel standard of care protocol, washing
      red cell and platelet transfusions for younger patients with acute leukemia, has yielded
      improved clinical outcomes at Strong Memorial Hospital (Rochester, New York, USA). This
      standard of care was implemented based upon an earlier randomized trial (BMC Blood Disorders.
      2004 Dec 10;4(1):6) The comparator will be historical controls from the medical literature.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to determine whether a novel standard of care protocol, washing
      red cell and platelet transfusions for younger patients with acute leukemia, has yielded
      improved clinical outcomes at Strong Memorial Hospital (Rochester, New York, USA). This
      standard of care was implemented based upon an earlier randomized trial (BMC Blood Disorders.
      2004 Dec 10;4(1):6) The comparator will be historical controls from the medical literature.
      Key outcomes will be treatment related mortality (deaths at 30, 60 and 100 days) and three
      year survival.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survial Rate at 30 Days</measure>
    <time_frame>30 days</time_frame>
    <description>The percentage of patients who were alive at 30 days after transfusion.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Survial Rate at 60 Days</measure>
    <time_frame>60 days</time_frame>
    <description>The percentage of patients who were alive at 60 days after transfusion.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Survial Rate at 100 Days</measure>
    <time_frame>100 days</time_frame>
    <description>The percentage of patients who were alive at 100 days after transfusion.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Survial Rate at 5 Years</measure>
    <time_frame>5 years</time_frame>
    <description>The percentage of patients who were alive at 5 years after transfusion.</description>
  </primary_outcome>
  <enrollment type="Actual">100</enrollment>
  <condition>Leukemia, Myeloid, Acute</condition>
  <condition>Leukemia, Lymphoblastic, Acute</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The study population is comprised of 98 men and women who were both diagnosed and treated
        for Acute Myeloid Leukemia or Acute Lymphoid Leukemia at Strong Memorial Hospital, a
        tertiary medical center located in Rochester, NY, USA. All of these patients received
        washed red cell and platelet transfusions as part of the hospital's standard protocol for
        patients with acute leukemia.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  previously untreated patients with a diagnosis of acute leukemia between the ages of 0
             and 50 (AML) and 18 and 50 (ALL)

        Exclusion Criteria:

          -  all other patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neil Blumberg, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rochester Medical Center, School of Medicine and Dentistry</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Strong Memorial Hospital (University of Rochester Medical Center)</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Blumberg N, Heal JM, Rowe JM. A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440]. BMC Blood Disord. 2004 Dec 10;4(1):6.</citation>
    <PMID>15588315</PMID>
  </reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 16, 2013</study_first_submitted>
  <study_first_submitted_qc>October 29, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 5, 2013</study_first_posted>
  <results_first_submitted>February 27, 2017</results_first_submitted>
  <results_first_submitted_qc>April 10, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">April 11, 2017</results_first_posted>
  <last_update_submitted>April 10, 2017</last_update_submitted>
  <last_update_submitted_qc>April 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rochester</investigator_affiliation>
    <investigator_full_name>Neil Blumberg</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Leukemia</keyword>
  <keyword>Transfusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Leukemia, Myeloid</mesh_term>
    <mesh_term>Leukemia, Myeloid, Acute</mesh_term>
    <mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Washed</title>
          <description>Washed red blood cell transfusions given to all patients with acute myeloid leukemia.</description>
        </group>
        <group group_id="P2">
          <title>Unwashed</title>
          <description>Transfusions of red cells were not washed before transfusion into the acute myeloid leukemia patient.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="69"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="69"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Washed</title>
          <description>Washed red blood cell transfusions given to all patients with acute myeloid leukemia.</description>
        </group>
        <group group_id="B2">
          <title>Unwashed</title>
          <description>Transfusions of red cells were not washed before transfusion into the acute myeloid leukemia patient.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="69"/>
            <count group_id="B2" value="31"/>
            <count group_id="B3" value="100"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40" lower_limit="1" upper_limit="50"/>
                    <measurement group_id="B2" value="30" lower_limit="2" upper_limit="49"/>
                    <measurement group_id="B3" value="35" lower_limit="1" upper_limit="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="64"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Survial Rate at 30 Days</title>
        <description>The percentage of patients who were alive at 30 days after transfusion.</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Washed</title>
            <description>Washed red blood cell transfusions given to all patients with acute myeloid leukemia.</description>
          </group>
          <group group_id="O2">
            <title>Unwashed</title>
            <description>Transfusions of red cells were not washed before transfusion into the acute myeloid leukemia patient.</description>
          </group>
        </group_list>
        <measure>
          <title>Survial Rate at 30 Days</title>
          <description>The percentage of patients who were alive at 30 days after transfusion.</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="69"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100"/>
                    <measurement group_id="O2" value="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Survial Rate at 60 Days</title>
        <description>The percentage of patients who were alive at 60 days after transfusion.</description>
        <time_frame>60 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Washed</title>
            <description>Washed red blood cell transfusions given to all patients with acute myeloid leukemia.</description>
          </group>
          <group group_id="O2">
            <title>Unwashed</title>
            <description>Transfusions of red cells were not washed before transfusion into the acute myeloid leukemia patient.</description>
          </group>
        </group_list>
        <measure>
          <title>Survial Rate at 60 Days</title>
          <description>The percentage of patients who were alive at 60 days after transfusion.</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="69"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97"/>
                    <measurement group_id="O2" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Survial Rate at 100 Days</title>
        <description>The percentage of patients who were alive at 100 days after transfusion.</description>
        <time_frame>100 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Washed</title>
            <description>Washed red blood cell transfusions given to all patients with acute myeloid leukemia.</description>
          </group>
          <group group_id="O2">
            <title>Unwashed</title>
            <description>Transfusions of red cells were not washed before transfusion into the acute myeloid leukemia patient.</description>
          </group>
        </group_list>
        <measure>
          <title>Survial Rate at 100 Days</title>
          <description>The percentage of patients who were alive at 100 days after transfusion.</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="69"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96"/>
                    <measurement group_id="O2" value="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Survial Rate at 5 Years</title>
        <description>The percentage of patients who were alive at 5 years after transfusion.</description>
        <time_frame>5 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Washed</title>
            <description>Washed red blood cell transfusions given to all patients with acute myeloid leukemia.</description>
          </group>
          <group group_id="O2">
            <title>Unwashed</title>
            <description>Transfusions of red cells were not washed before transfusion into the acute myeloid leukemia patient.</description>
          </group>
        </group_list>
        <measure>
          <title>Survial Rate at 5 Years</title>
          <description>The percentage of patients who were alive at 5 years after transfusion.</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="69"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55"/>
                    <measurement group_id="O2" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Serious, and Other (Not Including Serious) Adverse Events were not monitored/assessed</desc>
      <group_list>
        <group group_id="E1">
          <title>Washed</title>
          <description>Washed red blood cell transfusions given to all patients with acute myeloid leukemia.</description>
        </group>
        <group group_id="E2">
          <title>Unwashed</title>
          <description>Transfusions of red cells were not washed before transfusion into the acute myeloid leukemia patient.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>This is a cohort study and thus has limits as to confounding and bias. However, it reproduces the results of a previous single center randomized trial.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Neil Blumberg MD</name_or_title>
      <organization>University of Rochester Medical Center</organization>
      <phone>(585) 275-3189</phone>
      <email>neil_blumberg@urmc.rochester.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

